| Item type |
文献 / Documents(1) |
| 公開日 |
2022-09-20 |
| アクセス権 |
|
|
アクセス権 |
open access |
| 資源タイプ |
|
|
資源タイプ識別子 |
http://purl.org/coar/resource_type/c_6501 |
|
資源タイプ |
journal article |
| 出版社版DOI |
|
|
|
関連識別子 |
https://doi.org/10.3389/fonc.2021.809825 |
|
|
関連名称 |
10.3389/fonc.2021.809825 |
| 出版タイプ |
|
|
出版タイプ |
VoR |
|
出版タイプResource |
http://purl.org/coar/version/c_970fb48d4fbd8a85 |
| タイトル |
|
|
タイトル |
Combined Interstitial and Intracavitary High-Dose Rate Brachytherapy of Cervical Cancer |
| タイトル別表記 |
|
|
その他のタイトル |
Hybrid Brachytherapy of Cervical Cancer |
| 著者 |
イタミ, ジュン
ムラカミ, ナオヤ
ワタナベ, ミホ
セキイ, シュウヘイ
カサマツ, タカヒロ
カトウ, シンゴ
ヒロワタリ, ヒサコ
生島, 仁史
アンドウ, ケン
オオノ, タツヤ
オカモト, ヒロユキ
オオクマ, カエ
イガキ, ヒロシ
|
| 抄録 |
|
|
内容記述 |
High-dose-rate brachytherapy by remote afterloading is now performed under three-dimensional image guidance by CT or MRI. Three-dimensional image-guided brachytherapy in cervical cancer disclosed that the traditional intracavitary brachytherapy by Manchester method cannot deliver an adequate dose to the large tumor with resulting local recurrence. To improve the local control rate, combined interstitial and intracavitary (hybrid) brachytherapy can increase the dose to the large parametrial involvement without increasing the dose to the rectum and bladder. Whether hybrid brachytherapy can be performed safely on a multi-institutional basis remains to be studied. From 2015, phase I/II study of hybrid brachytherapy was launched in Japan, and it was revealed that hybrid brachytherapy can be performed safely and with a high quality of radiation dose distribution in a multi-institutional study. In Japan, the number of patients undergoing hybrid brachytherapy in cervical cancer is rapidly rising. Education and clinical trial are very important to establish hybrid brachytherapy in the management of cervical cancer. |
| キーワード |
|
|
主題 |
cervical cancer |
| キーワード |
|
|
主題 |
interstitial |
| キーワード |
|
|
主題 |
intracavitary |
| キーワード |
|
|
主題 |
brachytherapy |
| キーワード |
|
|
主題 |
three-dimensional image-guided |
| 書誌情報 |
en : Frontiers in Oncology
巻 11,
p. 809825,
発行日 2022-01-13
|
| 収録物ID |
|
|
収録物識別子タイプ |
ISSN |
|
収録物識別子 |
2234943X |
| 出版者 |
|
|
出版者 |
Frontiers Media SA |
| 権利情報 |
|
|
権利情報 |
This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY) . The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms. |
| EID |
|
|
識別子 |
389725 |
| 言語 |
|
|
言語 |
eng |
fonc_11_809825.pdf (2.13 MB)
.png)
